AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Precision Radiation Oncology Article
Article Link
Cite
EndNote(RIS) BibTeX
Collect
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Consensus | Open Access

Chinese clinical practice guidelines for the prevention and treatment of radiation-induced dermatitis

Ming Fan1,2,4, Mei Feng1,2,3( ), Shuanghu Yuan5,6 ( )
China Anti-Cancer Association Tumor Support Therapy Committee
China Anti-Cancer Association Tumor Radiation Protection Committee
Department of Hematology and Oncology, The Third People’s Hospital of Sichuan Province
Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China
Chinese Radiation Therapy Oncology Group
Department of Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
Show Author Information

Abstract

Radiation-induced dermatitis is one of the most prevalent complications in patients undergoing cancer radiotherapy and poses a significant challenge to cancer therapy. The symptoms include erythema, dry desquamation, and moist desquamation, which are frequently observed in patients with breast, head and neck, anal, and vulvar cancers. Early skin reactions typically manifest within 2–4 weeks following the initiation of radiotherapy. In severe cases, acute dermatitis can cause radiotherapy interruptions, prolong treatment time, and ultimately affect patient outcomes and quality of life. Currently, there are numerous guidelines on radiation dermatitis, including the Multinational Association of Supportive Care in Cancer (MASCC), British Columbia Cancer Agency (BCCA), Oncology Nursing Society (ONS), and UK Society of Radiographers (SCoR) guidelines. In China, dermatology experts have drafted a consensus. However, due to the differing backgrounds of experts, recommendations among guidelines vary. These guidelines were first developed by Chinese radiation oncologists. The evidence-based guideline in this paper fully considers and adopts China's national conditions; hence, it can be easily applied in daily practice.

Keywords

PreventionTreatmentAdverse reactionsClinical practice guidelinesRadiation-induced dermatitis

References

1

Wei J, Meng L, Hou X, et al. Radiation-induced skin reactions:mechanism and treatment. Cancer Manag Res. 2019;11:167-177.
Crossref Google Scholar
2

Salvo N, Barnes E, van Draanen J, et al. Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature. Curr Oncol. 2010;17(4):94-112.
Crossref Google Scholar
3

Hymes SR, Strom EA, Fife C. Radiation dermatitis:clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol, 2006;54(1):28-46.
Crossref Google Scholar
4

Wong RK, Bensadoun RJ, Boers-Doets CB, et al. Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group. Support Care Cancer, 2013;21(10):2933-2948.
Crossref Google Scholar
5

Finkelstein S, Kanee L, Behroozian T, et al. Comparison of clinical practice guidelines on radiation dermatitis: a narrative review. Support Care Cancer, 2022;30(6):4663-4674.
Crossref Google Scholar
6

Dermatological Aesthetics Group of Medical Aesthetics and Aesthetics Branch of Chinese Medical Association. Expert consensus on the diagnosis and treatment of radiation dermatitis. Chin J Med Aesthet Beaut, 2021;27(5):353-357.
Google Scholar
7

Bhangoo RS, Cheng TW, Petersen MM, et al. Radiation recall dermatitis:a review of the literature. Semin Oncol, 2022;49(2):152-159.
Crossref Google Scholar
8

Burris HA 3rd, Hurtig J. Radiation recall with anticancer agents. Oncologist, 2010, 15(11):1227-1237.
Crossref Google Scholar
9

Vinante L, Caroli A, Revelant A, et al. Radiation recall dermatitis induced by COVID-19 vaccination in breast cancer patients treated with postoperative radiation therapy. Breast, 2022;65:49-54.
Crossref Google Scholar
10

Tejwani A, Wu S, Jia Y, et al. Increased risk of high-grade dermatologic toxicities with radiation plus epidermal growth factor receptor inhibitor therapy. Cancer, 2009, 115(6):1286-1299.
Crossref Google Scholar
11

Dzul S, Ninia J, Jang H, et al. Predictors of acute radiation dermatitis and esophagitis in africanamerican patients receiving whole-breast radiation therapy. Pract Radiat Oncol, 2022;12(1):52-59.
Crossref Google Scholar
12

Córdoba EE, Lacunza E, Güerci AM. Clinical factors affecting the determination of radiotherapy-induced skin toxicity in breast cancer. Radiat Oncol J, 2021;39(4):315-323.
Crossref Google Scholar
13

Thomas A, Keller A, Menoux I, et al. Prognostic factors of acute radiodermatitis in breast cancer after adjuvant radiotherapy treated with RT3D or IMRT. Cancer Radiother, 2022, 26(5):684-691 (In French).
Crossref Google Scholar
14

Jagsi R, Griffith KA, Boike TP, et al. Differences in the acute toxic effects of breast radiotherapy by fractionation schedule: comparative analysis of physician-assessed and patient-reported outcomes in a large multicenter cohort. JAMA Oncol, 2015, 1(7):918-930.
Crossref Google Scholar
15

Hickey BE, James ML, Lehman M, et al. Fraction size in radiation therapy for breast conservation in early breast cancer. Cochrane Database Syst Rev, 2016;7(7):Cd003860. doi:10.1002/14651858.CD003860.pub4
Crossref Google Scholar
16

Pignol JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol, 2008;26(13):2085-2092.
Crossref Google Scholar
17

Shaitelman SF, Schlembach PJ, Arzu I, et al. Acuteand short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation:a randomized clinical trial. JAMA Oncol, 2015;1(7):931-941.
Crossref Google Scholar
18

Forster T, Köhler CVK, Debus J, et al. Accelerated partial breast irradiation: a new standard of care? Breast Care (Basel), 2020, 15(2):136-147.
Crossref Google Scholar
19

Coles CE, Griffin CL, Kirby AM, et al. Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial):5-year results from a multicentre, randomized, controlled, phase 3, non-inferiority trial. Lancet, 2017;390(10099):1048-1060.
Crossref Google Scholar
20

Whelan TJ, Julian JA, Berrang TS, et al. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID):a randomized controlled trial. Lancet, 2019;394(10215):2165-2172.
Crossref Google Scholar
21

Brunt AM, Wheatley D, Yarnold J, et al. Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial. Radiother Oncol, 2016, 120(1):114-118.
Crossref Google Scholar
22

He Y, Guo T, Guan H, et al. Concurrent chemoradiotherapy versus radiotherapy alone for locoregionally advanced nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: a meta-analysis. Cancer Manag Res, 2018;10: 1419-1428.
Crossref Google Scholar
23

Bonomo P, Loi M, Desideri I, et al. Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: a systematic review. Crit Rev Oncol Hematol, 2017;120: 98-110.
Crossref Google Scholar
24

Bonomo P, Desideri I, Loi M, et al. Management of severe bio-radiation dermatitis induced by radiotherapy and cetuximab in patients with head and neck cancer: emphasizing the role of calcium alginate dressings. Support Care Cancer, 2019;27(8):2957-2967.
Crossref Google Scholar
25

Yan BY, Wasilewski G, Lacouture ME, et al. Incidence of dermatologic adverse events in patients with cancer treated with concurrent immune checkpoint inhibitors and radiation therapy: A systematic review and meta-analysis. J Am Acad Dermatol, 2021, 84(3):871-875.
Crossref Google Scholar
26

Miller R, Song A, Ali A, et al. Scalp-sparing radiation with concurrent temozolomide and tumor treating fields (SPARE) for patients with newly diagnosed glioblastoma. Front Oncol, 2022;12: 896246. doi:10.3389/fonc.2022.896246
Crossref Google Scholar
27

Lewis L, Carson S, Bydder S, et al. Evaluating the effects of aluminum-containing and non-aluminum containing deodorants on axillary skin toxicity during radiation therapy for breast cancer: a 3-armed randomized controlled trial. Int J Radiat Oncol Biol Phys, 2014;90(4):765-771.
Crossref Google Scholar
28

Hawkins D, Abrahamse H. Effect of multiple exposures of low-level laser therapy on the cellular responses of wounded human skin fibroblasts. Photomed Laser Surg, 2006;24(6):705-714.
Crossref Google Scholar
29

Censabella S, Robijns J, Claes S, et al. Low level laser therapy for the management of radiation dermatitis: preliminary results of a pilotstudy in breast cancer patients. Ann Oncol, 2014;25:534.
Crossref Google Scholar
30

Chan R J, Webster J, Chung B, et al. Prevention and treatment of acute radiation-induced skin reactions: a systematic review and meta-analysis of randomized controlled trials. BMC Cancer, 2014;14:53.
Crossref Google Scholar
31

Ferreira EB, Vasques CI, Gadia R, et al. Topical interventions to prevent acute radiation dermatitis in head and neck cancer patients: a systematic review. Support Care Cancer, 2017;25(3):1001-1011.
Crossref Google Scholar
32

Haruna F, Lipsett A, Marignol L. Topicalmanagement of acute radiation dermatitis in breast cancer patients: a systematic review and meta-analysis. Anticancer Res, 2017, 37(10):5343-5353.
Crossref Google Scholar
33

Wu SX, Lan M. Local use of rhGM-CSF for the treatment of chemoradiotherapy induced oral mucositis. Drug Eval, 2012;9(30):4-7.
Google Scholar
34

Kouvaris JR, Kouloulias VE, Plataniotis GA, et al. Dermatitis during radiation for vulvar carcinoma: prevention and treatment with granulocyte-macrophage colony-stimulating factor impregnated gauze. Wound Repair Regen, 2001;9(3):187-193.
Crossref Google Scholar
35

Zhang LY, Chang YF, Wang BB, et al. Effect of protective spray against rays for medical use. Chin J Radiol Med Prot, 2006;26(6):597-599.
Google Scholar
36

Chan R J, Blades R, Jones L, et al. A single-blind, randomized controlled trial of StrataXRT® - A silicone-based film-forming gel dressing for prophylaxis and management of radiation dermatitis in patients with head and neck cancer. Radiother Oncol, 2019, 139:72-78.
Crossref Google Scholar
37

Rosenthal A, Israilevich R, Moy R. Management of acute radiation dermatitis: A review of the literature and proposal for treatment algorithm. J Am Acad Dermatol, 2019;81(2):558-567.
Crossref Google Scholar
38

Niazi TM, Vuong T, Azoulay L, et al. Silver clear nylon dressing is effective in preventing radiation-induced dermatitis in patients with lower gastrointestinal cancer: results from a phase Ⅲ study. J Radiat Oncol Biol Phys, 2012, 84(3): e305-310. doi:10.1016/j.ijrobp.2012.03.062
Crossref Google Scholar
39

Aquino-Parsons C, Lomas S, Smith K, et al. PhaseIIIstudy of silver leaf nylon dressing vs standard care for reduction of inframammary moist desquamation in patients undergoing adjuvant whole breast radiation therapy. J Med Imaging Radiat Sci, 2010, 41(4):215-221.
Crossref Google Scholar
40

Hemati S, Asnaashari O, Sarvizadeh M, et al. Topical silver sulfadiazine for the prevention of acute dermatitis during irradiation for breast cancer. Support Care Cancer, 2012, 20(8):1613-1618.
Crossref Google Scholar
41

Heggie S, Bryant GP, Tripcony L, et al. A Phase Ⅲ study on the efficacy of topical aloe vera gel on irradiated breast tissue. Cancer Nurs, 2002, 25(6):442-451.
Crossref Google Scholar
42

Hoopfer D, Holloway C, Gabos Z, et al. Three-arm randomized phase IIItrial: quality aloe and placebo cream versus powder as skin treatment during breast cancer radiation therapy. Clin Breast Cancer, 2015, 15(3):181-190.
Crossref Google Scholar
43

Farrugia CE, Burke ES, Haley ME, et al. The use of aloe vera in cancer radiation: an updated comprehensive review. Complement Ther Clin Pract, 2019, 35:126-130.
Crossref Google Scholar
44

Yao HJ, Zou LF, Wang MZ. Effect of applying aloe to prevent radiation injury of patients with skin malignancy. Chin J Nurs, 2006, 41(4):364-365.
Google Scholar
45

Elliott EA, Wright JR, Swann RS, et al. Phase Ⅲ Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13. J Clin Oncol, 2006;24(13):2092-2097.
Crossref Google Scholar
46

Pommier P, Gomez F, Sunyach MP, et al. Phase Ⅲ randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol, 2004;22(8):1447-1453.
Crossref Google Scholar
47

Sharp L, Finnilä K, Johansson H, et al. No differences between Calendula cream and aqueous cream in the prevention of acute radiation skin reactions-results from a randomized blinded trial. J Oncol Nurs, 2013, 17(4):429-435.
Crossref Google Scholar
48

Wang LY, Ren RM, Liu SL, et al. Clinical effect of Trolamine cream in preventing and treating radioactive skin destruction of breast carcinoma patients induced by simultaneous integrated boost intensity-modulated radiotherapy after breast-conserving surgery. Chin J Cancer Prev Treat, 2010, 17(19):1579-1580.
Google Scholar
49

Peng Y, Wu S, Yan GS, et al. Clinical Effect of Trolamine Cream to Prevent Irradiation-induced Dermal Injury. SICHUAN J Cancer Contr, 2007;20(3):189-190,196.
Google Scholar
50

Zhang JQ, Zhang L, Zhang L. Effect of trolamine (biafine) in preventing and treating radiationinduced dermal injury in head and neck carcinoma patients. J Pract Oncol, 2011;26(3):269-271.
Google Scholar
51

Wells M, Macmillan M, Raab G, et al. Does aqueous or Sucralfate cream affect the severity of erythematous radiation skin reactions? A randomized controlled trial. Radiother Oncol, 2004, 73(2):153-162.
Crossref Google Scholar
52

Censabella S, Claes S, Orlandini M, et al. Retrospective study of radiotherapy-induced skin reactions in breast cancer patients:reduced incidence of moist desquamation with a hydroactivecolloid gel versus dexpanthenol. Eur J Oncol Nurs, 2014;18(5):499-504.
Crossref Google Scholar
53

Kodiyan J, Amber KT. A review of the use of topical calendula in the prevention and treatment of radiotherapy-induced skin reactions. Antioxidants (Basel), 2015, 4(2):293-303.
Crossref Google Scholar
54

Kaul R, Mishra BK, Sutradar P, et al. The role of Wobe-Mugos in reducing acute sequele of radiation in head and neck cancers–a clinical phase-Ⅲ randomized trial. Indian J Cancer, 1999;36(2-4):141-148.
Google Scholar
55

Aygenc E, Celikkanat S, Kaymakci M, et al. Prophylactic effect of pentoxifylline on radiotherapy complications: a clinical study. Otolaryngol Head Neck Surg, 2004;130(3):351-356.
Crossref Google Scholar
56

Lin LC, Que J, Lin LK, et al. Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study. Int J Radiat Oncol Biol Phys, 2006;65(3):745-750.
Crossref Google Scholar
57

Ryan JL, Heckler CE, Ling M, et al. Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiat Res, 2013;180(1):34-43.
Crossref Google Scholar
58

Ryan Wolf J, Heckler CE, Guido JJ, et al. Oral curcumin for radiation dermatitis: a URCC NCORP study of 686 breast cancer patients. Support Care Cancer, 2018;26(5):1543-1552.
Crossref Google Scholar
59

Kouloulias VE, Kouvaris JR, Kokakis JD, et al. Impact on cytoprotective efficacy of intermediate interval between amifostine administration and radiotherapy: a retrospective analysis. Int J Radiat Oncol Biol Phys. 2004;59(4):1148-1156.
Crossref Google Scholar
60

Liu S, Wang YL, Shi ST, et al. The effect of recombinant human epidermal growth factor on radiation dermatitis in rectal and anal cancer patients: a self-controlled study. BMC Cancer, 2022;22(1):1140.
Crossref Google Scholar
61

Bazire L, Fromantin I, Diallo A, et al. Hydrosorb® versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicentre controlled randomized trial. Radiother Oncol, 2015;117(2):229-233.
Crossref Google Scholar
62

Bernier J, Bonner J, Vermorken JB, et al. Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Ann Oncol, 2008;19(1):142-149.
Crossref Google Scholar
63

Cai C, Zhu H, Chen Y, et al. Mechanoactive nanocomposite hydrogel to accelerate wound repair in movable parts. ACS Nano, 2022;16(12):20044-20056.
Crossref Google Scholar
64

Lee J, Lee SW, Hong JP, et al. Foam dressing with epidermal growth factor for severe radiation dermatitis in head and neck cancer patients. Int Wound J, 2016;13(3):390-393.
Crossref Google Scholar
65

Bernier J, Russi EG, Homey B, et al. Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines. Ann Oncol, 2011;22(10):2191-2200.
Crossref Google Scholar
66

Villavicencio M, Granados-García M, Vilajosana E, et al. Management of radiodermatitis associated with cetuximab in squamous cell carcinomas of the head and neck. Int J Dermatol, 2017;56(6):602-609.
Crossref Google Scholar
67

Zhu G, Lin JC, Kim SB, et al. Asian expert recommendation on management of skin and mucosal effects of radiation, with or without the addition of cetuximab or chemotherapy, in treatment of head and neck squamous cell carcinoma. BMC Cancer,2016;16(1):1-13.
Crossref Google Scholar
68

Pinto C, Barone CA, Girolomoni G, et al. Management of skin reactions during cetuximab treatment in association with chemotherapy or radiotherapy: update of the italian expert recommendations. Am J Clin Oncol, 2016;39(4):407-415.
Crossref Google Scholar
69

Magnusson M, Höglund P, Johansson K, et al. Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer:a phase two, double-blind, placebo-controlled randomized clinical trial (Ptx-5). Eur J Cancer, 2009;45(14):2488-2495.
Crossref Google Scholar
70

Jacobson G, Bhatia S, Smith BJ, et al. Randomized trial of pentoxifylline and vitamin E vs standard follow-up after breast irradiation to prevent breast fibrosis, evaluated by tissue compliance meter. Int J Radiat Oncol Biol Phys, 2013;85(3):604-608.
Crossref Google Scholar
71

Delanian S, Porcher R, Rudant J, et al. Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. J Clin Oncol,2005, 23(34):8570-8579.
Crossref Google Scholar
72

Gothard L, Stanton A, MacLaren J, et al. Non-randomized phase Ⅱ trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema and tissue fibrosis after radiotherapy for early breast cancer. Radiother Oncol, 2004;70(3):217-224.
Crossref Google Scholar
73

Santos-Juanes J, Coto-Segura P, Galache Osuna C, et al. Treatment of hyperpigmentation component in chronic radiodermatitis with alexandrite epilation laser. Br J Dermatol, 2009;160(1):210-211.
Crossref Google Scholar
74

Rossi AM, Nehal KS, Lee EH. Radiation-induced breast telangiectasias treated with the pulsed dye laser. J Clin Aesthet Dermatol, 2014;7(12):34-37.
Google Scholar
Precision Radiation Oncology
Volume 7 Issue 3,
September 2023
Pages 160-172
DOI: 10.1002/pro6.1208
Cite this article:
Fan M, Feng M, Yuan S. Chinese clinical practice guidelines for the prevention and treatment of radiation-induced dermatitis. Precision Radiation Oncology, 2023, 7(3): 160-172. https://doi.org/10.1002/pro6.1208

213

Views

0

Crossref

0

Scopus

Altmetrics
Received: 27 June 2023
Revised: 17 August 2023
Accepted: 21 August 2023
Published: 10 September 2023
© 2023 The Authors.

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Return